With new data now available for use of brentuximab in ALK positive, CD30 anaplastic large cell lymphoma, what is your first line regimen?  

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at NYU Winthrop Hospital
I agree, less toxic, better regimen.
Sign in or Register to read more